Photoaging Reversing After Picosecond Laser With DLA Assessed by Cellular Resolution OCT in Asian Patient With Melasma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

February 5, 2021

Study Completion Date

February 10, 2022

Conditions
Melasma
Interventions
DEVICE

PicoSure 755nm picosecond alexandrite laser with diffractive lens

Understand the role of 755nm picosecond alexandrite laser with diffractive lens of reversal of photodamage and improving the melasma by evaluation with optical coherence tomography and other noninvasive methods.

DEVICE

ApolloVue® S100 Image System

Understand the role of 755nm picosecond alexandrite laser with diffractive lens of reversal of photodamage and improving the melasma by evaluation with optical coherence tomography.

DEVICE

Cutometer® dual MPA 580

Understand the role of 755nm picosecond alexandrite laser with diffractive lens of reversal of photodamage and improving the melasma by evaluation with the Cutometer® dual MPA 580.

DEVICE

VISIA®

Understand the role of 755nm picosecond alexandrite laser with diffractive lens of reversal of photodamage and improving the melasma by evaluation with the VISIA®.

Trial Locations (1)

404332

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Apollo Medical Optics, Ltd

INDUSTRY

lead

China Medical University Hospital

OTHER

NCT04602819 - Photoaging Reversing After Picosecond Laser With DLA Assessed by Cellular Resolution OCT in Asian Patient With Melasma | Biotech Hunter | Biotech Hunter